Table 2

The predictive value of baseline ∆TSJ and ∆PEG for achievement of remission (logistic regression analyses)

		Months	DAS28<2.6	SDAI≤3.3	CDAI≤2.8	ACR/EULAR Boolean	DAPSA<4
∆TSJ	RA	3	0.97 (0.95 to 0.99) p<0.001	0.96 (0.94 to 0.98) p<0.001	0.95 (0.93 to 0.97) p<0.001	0.96 (0.94 to 0.98) p<0.001	0.95 (0.93 to 0.98) p<0.001
		6	0.97 (0.95 to 0.98) p<0.001	0.96 (0.94 to 0.98) p<0.001	0.96 (0.94 to 0.98) p<0.001	0.96 (0.94 to 0.98) p<0.001	0.95 (0.93 to 0.98) p<0.001
	PsA	3	0.92 (0.89 to 0.96) p<0.001	0.91 (0.86 to 0.95) p<0.001	0.93 (0.89 to 0.97) p=0.001	0.93 (0.88 to 0.98) p=0.004	0.91 (0.86 to 0.95) p<0.001
		6	0.94 (0.90 to 0.97) p=0.001	0.94 (0.90 to 0.98) p=0.003	0.93 (0.89 to 0.97) p=0.001	0.92 (0.88 to 0.97) p=0.002	0.93 (0.89 to 0.98) p=0.002

∆PEG	RA	3	0.96 (0.94 to 0.99) p=0.009	0.99 (0.99 to 0.998) p=0.012	0.99 (0.99 to 0.997) p=0.004	0.99 (0.98 to 0.996) p=0.001	0.99 (0.98 to 0.99) p<0.001
		6	0.99 (0.99 to 0.997) p=0.002	0.99 (0.98 to 0.99) p<0.001	0.99 (0.98 to 0.99) p<0.001	0.99 (0.98 to 0.995) p=0.001	0.99 (0.98 to 0.99) p<0.001
	PsA	3	0.89 (0.84 to 0.94) p<0.001	0.98 (0.98 to 0.99) p<0.001	0.99 (0.98 to 0.995) p=0.001	0.99 (0.98 to 0.99) p=0.001	0.99 (0.98 to 0.995) p=0.002
		6	1.00 (0.99 to 1.01) p=0.94	0.99 (0.98 to 0.995) p=0.001	0.99 (0.98 to 0.99) p<0.001	0.98 (0.97 to 0.99) p<0.001	0.99 (0.98 to 0.99) p=0.001

Data are displayed as OR (95% CI). Logistic regression analyses adjusted for age, sex, disease duration and smoking.
ACR, American College of Rheumatology; CDAI, Clinical Disease Activity Index; DAPSA, Disease Activity Index for PsA; DAS28, 28 joint disease activity score; EULAR, European League Against Rheumatism; PsA, psoriatic arthritis (n=1236); RA, rheumatoid arthritis (n=2735); SDAI, Simplified Disease Activity Index; ΔPEG, baseline patient's and evaluator's global assessment difference; ΔTSJ, baseline tender and swollen joint count difference.